SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-001659
Filing Date
2020-02-27
Accepted
2020-02-27 17:02:03
Documents
95
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cara-20191231x10k.htm 10-K 3720617
2 EX-4.3 cara-20191231ex439690843.htm EX-4.3 13716
3 EX-23.1 cara-20191231ex231cf72e8.htm EX-23.1 15195
4 EX-31.1 cara-20191231ex311b847e5.htm EX-31.1 12973
5 EX-31.2 cara-20191231ex312d6306e.htm EX-31.2 14474
6 EX-32.1 cara-20191231ex321e2784b.htm EX-32.1 13062
7 GRAPHIC cara20191231x10k001.jpg GRAPHIC 38334
  Complete submission text file 0001558370-20-001659.txt   13049262

Data Files

Seq Description Document Type Size
8 EX-101.INS cara-20191231.xml EX-101.INS 2825866
9 EX-101.SCH cara-20191231.xsd EX-101.SCH 76745
10 EX-101.CAL cara-20191231_cal.xml EX-101.CAL 81106
11 EX-101.DEF cara-20191231_def.xml EX-101.DEF 330596
12 EX-101.LAB cara-20191231_lab.xml EX-101.LAB 701241
13 EX-101.PRE cara-20191231_pre.xml EX-101.PRE 583109
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36279 | Film No.: 20663429
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences